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1. Introduction  
Hepatic steatosis is a commonly noticed and most prevalent condition among donated liver 
grafts. The pressing demand for organs and increased patient death rates while awaiting 
organ transplantation has led to the use of cadaveric livers with hepatic steatosis for 
transplantation. Recent data reported the use of steatotic liver grafts in 71% of cases 
(Noujaim et al., 2009). Moreover, to meet the organ shortage, the criteria for donation have 
been broadened to include donors with advanced age, hepatitis B and C viruses, neoplasms, 
and benign underlying diseases (Fondevila et al., 2009). The use of expanded-criteria donors 
(ECDs) and the donor risk index (DRI) are strategies that have been proposed to increase the 
donor pool (Feng et al., 2006). The Donor Risk Index (DRI) lists seven donor characteristics, 
together with cold ischemia time and location of the donor as risk factors for graft failure. 
DRI >1.7 is reported to be associated with shorter survival after liver transplantation 
(Palmiero et al., 2010). It is hypothesized that donor hepatic steatosis is an additional 
independent risk factor (Spitzer et al., 2010). It remains unclear which value micro and/ or 
macrovesicular steatosis have for the short and long term results after liver transplantation. 
Therefore, different papers report a safe use of grafts with a severe microvesicular steatosis 
(Fishbein et al., 1997; McCormack et al., 2007). However, steatosis is one of the most 
important factors affecting liver allograft function. Steatosis is common in several situations, 
including: obesity, diabetes, and alcohol abuse (Durand et al., 2008). Organ donation 
predictive factors for recipient survival were: age, viral status, and degree of liver steatosis. 
Liver transplantation for alcoholic liver disease showed the highest complication rate. 
Chronic liver rejection occurred more frequently in the AIH transplanted group. The most 
useful predictive factors for 1-year survival were urea/ creatinine and liver function tests. 
(Patkowski et al., 2009). In addition, transplantation of a liver with >25% steatosis was a risk 
factor for the development of a biliary complication (Baccarani et al., 2009). Nevertheless, 
macrovesicular steatosis is known as a risk factor for early graft dysfunction and graft 
failure. Most transplantation centres consider 60% the value limit for transplantability, while 
others have adopted 30% as a cut-off limit (D'Alessandro et al., 2010).  
Organ donor shortage continues to pose a significant problem. To ensure fair and 
transparent allocation of too few post-mortem grafts, the model of end-stage liver disease 
(MELD)-based allocation was implemented in the Eurotransplant area in December 2006. 
This has decreased the waiting list mortality rate from 20 to 10 %, but at the same time has 
reduced post OLT survival (1-year survival from almost 90% to below 80%), which is largely 
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due to patients with a labMELD score >30. Following MELD introduction, the regular 
allocation threshold increased from a matchMELD of initially 25 to a current value of 34. At 
the same time, the quality of donor organs has seen a continuous deterioration over the last 
10 - 15 years, e.g., 63% of organs have a donor risk index of > 1.5 (Schlitt et al., 2011). Among 
the several reasons that might play an important contributing role are the pressing organ 
demand and the increasing percentage of elderly donors with co-morbidities, such as 
steatosis hepatis, combined with a high MELD-Score of the recipient at the point of 
transplantation. MELD >30 currently represents a major risk factor for outcome after liver 
transplantation. However, risk factors differ in individual patient subgroups (Weismuller et 
al., 2011). There has been data supporting the use of ECD organs in good-risk recipients. 
These include grafts from donors that are 60 years old, with prolonged hypotension, or with 
mild to moderate macrovescicular steatosis (Amin et al., 2004). The frozen-section 
histological evaluation of biopsies from cadaveric liver donors is an accurate, time-effective, 
and predictive method for the assessment of graft suitability. Nevertheless, it is discussed 
controversially if frozen-section histological evaluation of biopsies is a safe and efficient 
method in detection of macro- and microvesicular steatosis. Therefore, it is reported that 
validated pretransplant frozen-section analysis is a reliable technique when the maximum 
value for organ transplantation was 60% steatosis. Thus, the usefulness of another technique 
to support a more precise steatosis evaluation is recommended (D'Alessandro et al., 2010).  
2. Brain death, permission and intensive care treatment 
When brain death is determined according to actual guidelines, donors are selected for 
potential organ donation after permission is given. The diagnosis of brain death requires the 
absence of brain-stem reflexes and respiratory drive in a normothermic, non-drugged, 
comatose patient with a known irreversible brain lesion and no contributing metabolic 
derangements. Permission for organ donation has to be given considering the current 
transplantation law in the procurement country. While the donor liver is allocated further 
intensive care treatment is still necessary. Hepatic function is impaired after brain death. 
There is depletion of hepatic glycogen and a reduction in hepatic sinusoidal perfusion that 
occurs because of leukocyte activation and accumulation in the microcirculation (Smith, 
2004). It is unclear if the application of cortisone reduces the leukocyte activation in the liver 
tissue. Maintenance of cardiovascular, pulmonary and endocrinological stability is 
important for successful organ transplantation. The goals in managing the hemodynamic 
status of the donor are: to achieve normovolemia, maintain blood pressure, and optimize 
cardiac output, so as to achieve gradients of perfusion pressure and blood flow that promote 
organ function with the use of the least amount of vasoactive-drug support. Diabetes 
insipidus results from the absence of vasopressin after the destruction of the posterior 
pituitary gland. It contributes to hyperosmolarity, hemodynamic instability, and electrolyte 
abnormalities (e.g. hypernatremia) as a consequence of an excessive loss of free water. These 
effects should be prevented, because hypernatremia leads to osmotic gradients at the liver 
cell with consecutive cell swelling in the recipient after liver transplantation. However, 
recent data suggests that transplant measures of early liver function and risk of failure, up to 
1-year post-transplant, do not differ significantly based on peak or terminal donor serum 
sodium levels. These results indicate that donor serum sodium level likely has little clinical 
impact on post-transplant liver function. (Dictus et al., 2009; Kutsogiannis et al., 2006; 
Mangus et al., 2010; Shah, 2008; Wood et al., 2004).     
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3. Surgical procurement 
The surgical technic of organ procurement has been reported earlier by Rosenthal et al. in 
1983. The following chapter briefly resumes the major important aspects. The necessary 
technical details, depending especially on the combination of organs to be removed, are: 
wide exposure, dissection of each organ to be removed up to disconnection from the 
circulation while the heart is still beating, placement of cannulas for in-situ cold perfusion, 
orderly removal of the organs with cold perfusion protection of the organs to be removed 
last. In instances of liver and kidney procurement only, a midline sternal splitting incision is 
not routinely used, but can provide immediate access to the heart if there is any instability 
and can help to remove the liver more gently. After wide abdominal exposure, liver 
mobilization is carried out first, since this is the most meticulous dissection and attention to 
hemostasis is strict. Careful inspection of the arterial anatomy is done first; any anomalous 
arteries must be preserved. A branch to the left lobe is sometimes seen arising from the left 
gastric artery and can be seen in the superior portion of the gastrohepatic ligament. A 
branch to the right lobe arises from the superior mesenteric artery. This artery has 
occasionally been the entire arterial supply to the liver. The hepatic artery is dissected from 
the aorta. The common bile duct is exposed at its entrance to the pancreas and transected. 
The portal vein is dissected after transection of the pancreas to facilitate exposure. The 
inferior mesenteric and coronary veins are ligated; the splenic and superior mesenteric veins 
are mobilized. The junction of the inferior caval vein and right heart is identified, to provide 
maximal length of upper cuff of the vena cava. The liver is essentially ready for removal at 
this point. Cannulas are then placed for in-situ perfusion and crushed ice is immediately 
applied for cooling the external abdomen. First, cannulas are placed in the vena cava and 
aorta at their respective bifurcations and the vessels divided distally. Heparin 300 units/ Kg 
is given to prevent clotting (Rosenthal et al., 1983). Today, liver procurement is mostly 
performed by local surgeons experienced in at least ten organ donations as required. Liver 
preservation is realised using Histidine-Tryptophan-Ketoglutarate solution (Custodiol®) or 
University of Wisconsin solution (Viaspan®) as preservative. 
4. Surgical evaluation 
A successful evaluation of a liver graft for transplantation is based on several essential 
criteria: donor medical history, laboratory data on liver function, virological analysis, 
sonography, as well as intraoperative liver exploration particular for colour and palpation. 
Identifying marginal from good donor livers is one of the most difficult surgical tasks. Thus, 
surgical experience and evaluation criteria have increased importance in liver 
transplantation. Visual inspection and palpation are the most commonly used methods for 
surgeons to establish liver quality. The positive predictive value of a surgical appraisal of 
liver steatosis has been reported to be 71% for severe; 46% for moderate; and 17% for mild 
steatosis (Adam et al., 1991). When donor surgeons suspect steatosis by inspection of a liver 
graft, a frozen section is only performed in 38% to 47% of cases (Nocito et al., 2006). 
However, for a successful evaluation and consequent transplantation, reliable and objective 
means are needed to assess the liver before transplantation. Histopathological examination 
should provide a helpful decision for the transplant surgeon whether or not the organ is 
suitable for transplantation. Therefore, in all cases of organ procurement a wedge biopsy of 
1-cm side length should be performed in two liver segments, one for each liver lobe (i.e., 
segments 3 and 6 or 7) (Frankel et al., 2002; Rey et al., 2009). 
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Fig. 1. The surgical evaluation of organ donor livers before preservation in situ. 
To evaluate liver quality is one of the most difficult surgical challenges during organ 
procurement. Therefore visual inspection and palpation are the most commonly used 
methods in situ before liver preservation. At this time liver biopsy is mostly required. 
 
  
Fig. 2. After liver preservation and procurement surgical evaluation of graft quality will be 
repeated.  
After liver procurement the graft´ s quality will be evaluated again by the donor surgeon. 
Surgical and anatomical characteristics are documented and communicated to the transplant 
coordinator and transplant surgeon. So far the liver biopsy results should be available. 
Finally, the graft is packaged into three bags of aseptic fluid. 
5. Frozen section 
Frozen section examination is useful in excluding donor organs which may become 
dysfunctional after transplantation. It has been shown that primary non-function has 
significantly decreased using frozen section examination (Markin et al., 1993).  
If a frozen section is required, the procedure consists of the following principal steps: the 
surgeon should take a wedge biopsy of 1-cm side length. The wedge will be split 
lengthwise; one half is snap frozen in liquid nitrogen from which 3 - 4-µm-thick sections are 
cut, briefly fixed in 4% buffered formalin (pH 7.4), rinsed, and counterstained with H&E. 
After dehydration in rising concentrations of alcohol, the section is coverslipped and 
analyzed by routine light microscopy.  
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In order to obtain a frozen section of high enough quality, a number of important aspects 
have to be considered in frozen section technique of liver tissue, being outlined in the 
following passage, even though we assume that any pathologist will be familiar with the 
principle of frozen section cutting. Once the wedge is split longitudinally, the obtained 
section should be placed with its cauterized side down, flatly upon the frozen section chuck. 
When placing the sectioned tissue, this thickness should guarantee cauterization artifacts 
extending to the freshly cut surface. This is increasingly important, if the actual tissue area is 
small, being crucial in wedges with less than 0.5cm wedge length. Irrespective of the actual 
wedge length, the area of the section should not extend beyond 1.0 cm2. If the wedge is 
bigger, splitting it into two should be considered and each piece analyzed by frozen section 
separately to obtain a picture of the entire area. A biopsy is considered to be sufficiently 
large, if it contains at least 10 cross sections of portal tracts. The number of portal tracts has 
to be documented to ensure a sufficient quality control. In addition, at least 4 sections of 3 – 
5 µm each should be cut and stained with H&E, to be able to analyze tissue alterations on 
several sections in sequence and in order to evaluate their importance. This will help to 
properly identify artifacts due to the procedure itself, such as uneven cuts, folds, shattering 
or rips of the section.  
The problems of inadequate equilibration to the correct temperature are several fold (Fig. 3). 
The temperature of the equipment, i.e. the knife, the chuck, and the cutting table itself as 
well as that of the frozen tissue should be at least –200C and kept constant. This means 
equilibration time for the frozen tissue and the newly introduced section blade. Ideally, the 
“optimal”  temperature is reached, when the cut section flows over the knife in a smooth 
uniform sheet with minimal curling. This, however, may mean taking the time to make 
adjustments to the cryostat temperature, which is time well spent to optimize the outcome, 
considering the consequences of rejection due to bad sectioning technique. A block that is 
too cold will quickly curl in an unmanageable way or shatter, creating a Venetian blind-like 
artefact. The tissue can be condensed if it is too cold, and it will even be tougher to cut, 
resulting in thick and thin sections. In contrast, if the block is too warm it results in a 
crumpled section. Thus, when placing the section itself, a layer of freezing compound with a 
flat surface has to be provided on the pre-cooled, and well cleaned chuck first, on which the 
freshly cut section is placed and completely covered by freezing compound medium. To 
obtain optimal freezing results, either a pre-cooled (at –20 0C) metal block is placed on top of 
the section or a freezing spray can be used. The former is helpful when larger tissue sections 
need to be frozen, the latter is best when the tissue section is small. Care has to be taken to 
avoid compression. Larger sections will not be satisfactorily frozen by spray, which may 
lead to uneven freezing with subsequent shattering of the section taken. In addition, using a 
spray leads to creation of an aerosol, which can be detrimental when the fumes are inhaled 
(i.e. cardiac arrythmia etc). To prevent inhalation, the lid of the cryostat compartment 
should be closed transiently to let the fumes settle. 
Cutting into the frozen tissue block is best done when the block is placed in such a way that 
the knife starts cutting at one of the corners of the wedge, since the liver capsule is normally 
harder than the parenchyma, leading to the compression of the softer hepatic tissue, 
shattering or ripping of the section, if the capsule is transected longitudinally first. In 
addition, the frozen tissue should be well cut into with several sections before using any for 
analysis, in order to avoid freezing artefacts and guarantee that the entire area is well 
exposed and sectioned.  
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Fig. 3. Problems in cutting frozen section. Venetian blind – like artefacts (left), and sub-
optimally preserved liver parenchyma (right) do not allow proper evaluation, particularly 
microvesicular steatosis 
Besides technical problems, cutting a frozen liver section may cause unexpected trouble 
based on primary parenchymal alterations, such as increased hepatocellular fat deposition.  
In this case, lower cryostat temperatures of –25 0C can be helpful, provided there is time for 
equilibrating the equipment, the knife and the tissue to this temperature first, which may 
take about 20-30 minutes depending on the size of the frozen tissue specimen. This delay in 
processing being worthwhile on one hand, may be problematic on the other, when the 
allotted time for pathologic evaluation is short due to logistical problems of time consuming 
transport for the frozen section material or the delivery of the liver specimen. 
 
  
Fig. 4. A wedge biopsy of 1-cm side length. The wedge will be split lengthwise; one half was 
snap frozen in liquid nitrogen. 
For subsequent analysis of the frozen tissue, it is post-fixed in 4% buffered formalin and 
paraffin embedded. For that purpose, the frozen tissue should be taken out of the cryostat 
and allow to thaw just enough to be taken safely from the chuck. The majority of the 
compound medium starting to thaw should be removed and the tissue placed immediately 
into formalin. The remaining rest of the compound medium does not effect the subsequent 
fixation procedure. The procedure of subsequent analysis is equal to that of the rest of the 
wedge, namely being immediately fixed and paraffinized. It is prudent to wait with the 
fixation of the rest of the wedge tissue, in case a second frozen section is needed, which 
should not be a problem, if the wedge is of sufficient size. Meanwhile, the wedge tissue 
should be kept on ice.  
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Fig. 5. Several 3-4 µm thick sections are cut after the tissue block is well cut in to expose 
flatly its entire surface. 
The most frequently encountered problem is the evaluation of hepatocellular, 
microvesicular steatosis (Fig. 6). If the tissue is not well preserved or suboptimally frozen, 
the subsequent frozen section may prove uncuttable at the thickness of 3 µm, which would 
allow optimal identification but instead has to be cut thicker. This setting will prevent 
meaningful analysis of the percentage of microvesicular steatosis. In contrast, 
macrovesicular steatosis is less influenced by section thickness, unless it exceeds 5 µm, but 
the accuracy of prediction will be lower, posing a possible problem in cases where the 
extend of steatosis reaches a critical level, potentially even leading to the rejection of the 
transplant in question. Staining methods for fat accumulation are available for frozen 
section as well as for paraffinized material. However, in a paraffin section, good (and thin) 
section quality is sufficient in our opinion to reliably recognize the degree of steatosis, while 
there is the danger that usually buffered, 4% formalin fixation and subsequent paraffin 
embedding will dissolve many fat droplets, particularly if they are of the microvesicular 
kind so that the fat stain will not show the true amount of deposition. The problem in frozen 
section lies again in the section’s thickness: while thicker sections give better staining results, 
they do not allow good identification of the degree of microvesicular fat deposition, while 
macrovesicular fat deposition does not require a fat stain. In addition, the staining solution 
should be used within a week after preparation, which means that frequently the solution 
will have to be freshly made.   
 
  
Fig. 6. Microvesicular steatosis:  3 µm thick sections on the left allow optimal evaluation, 
while the 5µm thick section on the right will lead to under estimation of steatosis. 250X; HE 
Stain 
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The other main finding in frozen section liver biopsies concerns the evaluation of 
parenchymal fibrosis. Here, an increased section thickness will lead to over estimation of the 
degree if fibrosis as well as potential misjudgement of the width of the liver sinus versus the 
hepatic trabeculae. While the sinuses will appear small, the trabeculae seem broader than is 
actually the case. This deception may be important to keep in mind, when the question of 
liver congestion with potential hemosiderin deposition arises.  
In case focal, nodular lesions are encountered on an otherwise normal appearing liver, a 
frozen section is mandatory, if the organ is principally regarded as transplantable by the 
surgeon. Here, it is helpful when the entire lesion is excised such that the surrounding 
normal liver tissue is part of the excision, in order to be able to evaluate the edge of the 
lesional process (infiltrative or smooth). However, this resection is not sufficient for the 
histopathological evaluation: besides the excisional biopsy, the regularly taken biopsies 
from segment 3 and 6 or 7 should be also be performed, because they enable the 
pathologist to analyse the quality of the liver and its alterations independently from the 
lesion.  
6. Histopathological evaluation during organ procurement 
Standards for histopathological evaluation of liver biopsies are still lacking. We recommend, 
based on our experience that frozen section should be taken within a side length of 1 cm 
minimum and not only from the liver surface. The pathologist needs sufficient clinical and 
surgical data for diagnosis. The frozen section should be evaluated when material is post-
fixed by a second pathologist for quality standard reasons. These results must be 
communicated to the transplantation center immediately. The pathologic evaluation, 
however, should not only include histopathologic findings, but also be extended to other 
primarily macroscopic findings such as: arteriosclerotic damage to the vessels, subcapsular 
cysts, and tumors, as well as bile duct abnormalities, since those findings may prevent 
transplantability  despite a well preserved liver parenchyma. 
One of the most frequently encountered problems is the size of the wedge itself. 
Occasionally, not a wedge but a crescent-like slice of hepatic tissue parallel to the surface is 
taken, and is almost always the only tissue for frozen section and only from the left liver 
lobe. This procedure is inadequate in several ways: (i) the amount of hepatic tissue is too 
small; (ii) there are clearly less than 10 portal tracts in this small excision; (iii) the closeness 
to the capsule may incorrectly suggest a fibrotic process, leading to rejection of the organ; 
(iv) a biopsy of only one (mostly left) liver lobe is insufficient; it cannot be assumed that the 
unbiopsied (mostly right) lobe is of equal quality or shows the same pathologic process. By 
analysing explanted but not-transplanted livers over the past 5 years, we encountered the 
practice of taking a crescent–like slice in several cases. In almost all cases, the evaluation 
resulted in rejection of the transplant organ, which after a complete work-up with histologic 
evaluation of all liver segments, could not be supported from the pathological analysis. The 
risk of prolonged bleeding with additional measures from the surgeon has been cited as a 
reason for taking a cresent-like slice in individual cases. While any procedure complicating 
the evaluation of the transplant should be principally avoided, this reasoning appears 
unacceptable since there should be sufficient time for arrest of bleeding while the frozen 
section is performed. 
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As far as differences between the liver lobes are concerned, we have learned from our study 
of explanted livers that in all but one case (out of 50) the degree of fibrosis or steatosis did 
not significantly vary among the different liver segments or the liver lobes (Rey et al., 2009). 
However, our single case with focal biliary cirrhosis in the right, but nor the left liver lobe, 
(Fig. 7) supports the concept of taking a wedge biopsy from both liver lobes. 
 
  
Fig. 7. Differences between liver lobes:  Originating from the same liver, the left picture 
shows the parenchyma of the right lobe with bridging fibrosis and widened bile ducts due 
to focal bile duct obliteration, while the right picture shows a section from the left lobe with 
well preserved parenchyma. The liver was rejected from the surgeon with the argument that 
since the right lobe representing two thirds of the liver was “cirrhosed”, (with no additional 
frozen section done), the “remaining” unchanged left lobe was not sufficient to transplant 
the organ. 40x; Gomori stain. 
Similarly, a focal fat accumulation in alcoholic livers may be taken for an increased steatosis 
not present in the remaining liver. This opinion is in contrast to current literature which has 
demonstrated that a single liver biopsy adequately represents the histologic characteristics 
of the liver (Lo et al., 2008). It has been reported that left and right lobe biopsies obtained 
during diagnostic laparoscopy have a highly significant histologic correlation for necrosis, 
steatosis, inflammation, and fibrosis (Picciotto et al., 1983). Nevertheless, the overall 
importance for adequate histopathological characteristic of the liver parenchyma during 
organ procurement requires a wedge biopsy with at least 10 portal tractions, and not a 
superficial biopsy from the liver surface.  
As we reported earlier, the colour of the liver surface is insufficient as major criteria in 
making the decision of transplantation or rejection. The quality of perfusion, the light 
quality of the operating room, the surgeons experience as well as different degrees of 
steatosis may greatly diminish the reliability of these criteria. Thus, if the quality of the 
organ appears doubtful, a frozen section is mandatory. 
When a liver is biopsied in order to evaluate it’s transplantability, several crucial questions 
have to be answered by the evaluating pathologist.  The most important question is whether 
the tissue has a lesion or not. The answer depends largely on the quality of the tissue and 
particularly on the quality of the frozen section, as previously outlined. While highly 
abnormal lesions, such as a diffuse macrovesicular fat deposition or complete liver cirrhosis, 
pose hardly any problem even if the frozen section is suboptimal. In contrast, the so called 
marginal organ lesions, such as mild fibrosis or microvesicular fat deposition, will be under 
diagnosed (because the bad quality of the section does not allow identification of these 
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changes) and regarded as transplantable without restriction. This could pose a problem in 
posttransplant management. On the other hand, changes that are over diagnosed lead to a 
premature rejection. 
Once the pathologist decides that there is a lesion, the question arises whether this lesion is 
focal or diffuse. Diffuse processes are expected to appear in all liver segments alike, as we 
could appreciate from our study from explanted, but not allocated livers, in which all 
segments were investigated histologically. The nature of these processes, such as: alcoholic 
damage, hepatitis B, or C, cannot be evaluated with certainty by frozen section.  
Most important is the evaluation of focal lesions. As table 1 lists, there are several with 
different pathophysiology to be considered. The information from the primary evaluating 
surgeon is of great importance. It should state whether there is indeed a single focal lesion, 
its location (subcapsular; right versus left liver lobe), its macroscopic appearance (colour, 
size, tissue density), and most importantly, whether the excised tissue encompasses the 
entire lesion or only a part. 
 
  
Fig. 8. Focal lesions: on the left, a thick walled cyst, differentially a simple cyst as well as an 
echinococcal cyst may be considered. On the right, a typical sclerosed lesion with a potentially 
difficult differential between a (rare) sclerosed malignant process or - as revealed itself on 
consecutive sections – a (frequently encountered) sclerosed hemagioma. 40x; H&E stain. 
In the following section, the main focal lesions which may be encountered in a frozen 
section are briefly listed and their relevance outlined. At first, the pathologist must 
differentiate between malignant and benign focal lesions. Among the malignant lesions, the 
most important ones are metastatic foci, which may originate from a large variety of different 
sources, among them the gastrointestinal, the urogenital, and the respiratory tract. In 
women, breast and ovary have to be considered. However, in the biopsy these differentials 
cannot be made. Currently, such livers are regarded as non transplantable, but in the future 
with the tendency of increasing organ demands, the question to transplant a liver with a 
metastatic or malignant lesion may be reconsidered depending on the lesion and the clinical 
evaluation. The other differential of a focal malignant lesion arising in an otherwise normal 
liver is a hepatocellular carcinoma (HCC). Albeit rare, the identification of such a lesion in a 
frozen section may be challenging or even impossible, if no normal liver tissue is included 
for comparison. While the typically thickened plates (being often more than 4 cells wide) are 
easily identified, the nuclear changes (increased size and nucleoli) can be hard to discern 
due to artificial swelling of the frozen tissue. Here, the transition from the tumour to the 
normal surrounding liver as well as plentiful mitoses is helpful. Rare tumour entities 
encountered are sarcomas, such as: angiosarcoma, leiomyosarcoma, fibrosarcoma, 
rhabdomyosarcoma, as well as malignant fibrous histiocytoma.  
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Simple cysts vs. Echinococcal cyst 
Congenital cystic disease 
Cystic mesenchymal hamartoma 
Hemangioma  (capillary vs cavernous) 
Hemangioendothelioma 
Biliary hamartoma 
Lymphangiomatosis 
Angiomyolipoma 
Focal fatty change 
Heterotopia 
prolonged ischemia (cold/ warm)  
 
Focal nodular hyperplasia 
Liver Cell Adenoma 
Nodular, regenerative Hyperplasia 
Peliosis hepatis 
Biliary adenoma 
HCC in normal liver      
Sarcomas 
 
Table 1. Focal lesions in the liver as important differential diagnosis in frozen section 
Benign focal lesions are numerous, but differ in the frequency that they are encountered. 
Among the most frequent are benign, simple cysts, hemangiomas and biliary hamartomas. 
All lesions can be found in subcapsular localization. Non-paracytic cysts are typically filled 
with a clear liquid, having an almost transparent wall and often a flat, sometimes a cuboidal 
or columnar epithelial lining. They are composed of mature connective tissue and are 
occasionally calcified. Macroscopically, they can be viewed as problematic when they are 
bled in. Differentially, an echinococcal cyst should be considered, although remnants of 
scolices may be undetectable. Congenital autosomal dominant or recessive cystic disease can be 
found in some cases; here the identification of renal and pancreatic cysts is important. 
Depending on the degree of cyst formation, even those organs may be considered 
transplantable (Rey et al., 2009). In children, a cystic mesenchymal hamartoma of childhood 
should be considered, whenever a pediatric liver transplant is in question. This occurs 
typically in the right liver lobe at the age of 16 months to 5 years. These hamartomas are 
mainly composed of connective tissue with small foci of remnants of liver cells, duct cells, 
even portal tissue.  
Among angiomatous lesions, the capillary and the cavernous hemagioma are the most 
frequently accounted subcapsular lesions. Here, a predilection of the right liver lobe, and the 
female gender is found for the cavernous subtype. Histologically, the typical appearance is 
multiple, dilated blood-filled spaces lined with mature flat epithelium, separated by fibrous 
tissue. Problems arise from the tendency of these lesions to undergo regression and fibrosis, 
which may make it difficult to differentiate them from potential malignant lesions. 
Hemangioendotheliomas can be found as focal lesions in childhood as well as in adult livers, 
although multiple foci throughout the liver may be encountered in childhood. Their 
histologic appearance is characterized by vascular spaces variable size, lined by immature 
plump endothelial cells.  
Regarding the number of cases, the most difficult decisions to be made are those in which a 
sclerosing hemangioma has to be differentiated from hemangioendothelioma or bile duct 
adenocarcinoma. While the evidence of erythrocytes is helpful, all lesions are prone to 
bleeding and the evaluation of nuclear and cytoplasmic atypia can be severely hampered by 
the sub-optimal quality of a frozen section. Here, a series of sections should be taken. 
However, in the few cases encountered with some uncertainty left inspite of a frozen 
section, the liver was rejected as transplant organ. Subsequent analysis of these livers 
revealed that the lesion was a sclerosing hemangioma. 
Biliary hamartomas, also called cholangiohamartoma or von Meyenburg complexes, are 
congenital lesions of a disturbed restructuring of the ductal plate (Chung, 1970). They 
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represent cystic spaces lined by bile duct epithelium and fibrotic obliteration of intrahepatic 
bile ducts (Woolf&Vierling, 1993). Depending on the localisation and prevalence of cystic 
ectasia and fibrotic obliteration, several disease entities can be differentiated ranging from 
the congenital hepatic fibrosis to the Caroli syndrome (Caroli, 1968). The lesions can be 
found as single or multiple subcapsular foci sharply demarcated and firm, being of grey-
white colour and wedge-shaped; their size ranging from 0.5 to 1.0 cm. Cellular atypias are 
missing. Occasionally, small microhamartomas have to be differentiated from fibrotic portal 
tracts. However, the presence or absence of portal veins and arteries should enable the 
correct diagnosis. 
Rarely, a lymphangiomatosis is found (Van Steenbergen et al., 1985). This solitary lesion is 
normally located intrahepatically and thus will normally not present itself to the 
evaluating surgeon. It has to be differentiated from a cavernous hemangioma since it can 
contain blood, besides cell debris and protein-rich fluid. If it is encountered, a systemic 
form (present in different organs) has to be recognized versus a sporadic, exclusively 
hepatic form. 
Another benign but tumour-appearing lesion is a nodule with focal fat accumulation typically 
observed in livers from patients with high alcohol consumption (Brawer et al., 1980). This 
lesion can also be rarely found after tetracycline intake (Peters et al., 1967). Histologically, 
intrahepatic fat deposition and regional necrotic hepatocytes with inflammatory 
demarcation is seen.  
An angiomyolipoma is yet another, mostly unexpected solitary finding, consisting of vessels, 
smooth muscle and fat tissue as well as medullary marrow. Normally of small size, it may 
be enlarged up to 20cm (Nonomura et al., 1994). 
Ischemic transplant damage or damage to suboptimal organ perfusion, hypotonia and shock of 
the donor should be considered, if liver cell necrosis, hepatic fat deposition and cholestasis 
are observed. Prolonged cold ischemia will damage the sinusoidal cells; prolonged warm 
ischemia the hepatocytes (Schon et al., 1998).  
Two other lesions can be challenging in frozen sections: focal nodular hyperplasie (FNH) 
versus adenoma (table 2). In ¾ of all cases, FNH represents an unexpected finding 
(Goodman, 1987) in women between the age of 20 and 50 years. Typically it is a solitary 
lesion (80%) and less frequently a multiple lesion (10% two foci, 10% >2 foci) 
predominantly in the right liver lobe. Star-like fibrotic strands have given the lesion the 
misnomer “ focal cirrhosis” . Thus, only a biopsy will be able to differentiate between this 
and genuine fibrotic/ cirrhotic lesions. The picture is characterized by fibrovascular and 
ductular areas radiating from the septa, accompanied by an expanding periphery of 
normal-appearing hepatocytes . While cells may appear polymorph, no dysplasia is seen. 
Glycogen and fat deposition is present. Intracanalicular bile cylinders can be found as 
well as bile duct proliferation. In contrast, a liver cell adenoma is a lesion almost exclusively 
found in women in their 3rd to 4th decade. Partially surrounded by a pseudo-capsule made 
from compacted liver cells, it consists exclusively of hepatocytes 2-3 layers wide lined 
with regular sinusoids, but without any portal tracts or bile ducts. If focal areas of 
immature connective tissue are found, a mesenchymal hamartoma should be considered 
instead. 
Nodular regenerative hyerplasia  or nodular transformation are small nodules, up to 0.6cm, which 
represent parenchymal regeneration present in non-cirrhotic livers versus multiacinar 
nodules without (type 1) or with (type 2) epithelial dysplasia mostly occurring in cirrhotic 
livers (Nakanuma, 1990). 
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 Focal Nodular 
Hyperplasia (FNH) 
Liver Cell Adenoma 
Location right liver lobe, 
subcapsular; ev. multiple
subcapsular; solitary 
80% 
Central scar present absent 
Fibrous septae frequent rare 
Bile ducts and portal tracts present absent 
Parenchymal lesion nodular homogenous 
Hemorrhage and necrosis rare frequent 
Cholestasis mild enhanced 
Capsule 
absent 
Partial to ample 
encapsulation 
Vascularity Vessel with broadened 
walls 
Thin walled vessels 
(sinusoids) 
Table 2. Relevant findings for frozen section evaluation between FNH and liver cell 
adenoma 
A biliary adenoma is a small, firm, white appearing nodule of less than 1 cm in diameter 
consisting of proliferating bile duct epithelium in subcapsular location. Focal inflammatory 
obliteration of a bile duct by may even lead to a cirrhotic alteration of an entire liver 
subsegment, which being located under the capsule, can be taken as a pars pro toto change of 
the entire liver. In our particular case, this resulted in rejection by the surgeon, again without 
further liver biopsy of other segments, which would have revealed the focality of the process. 
Peliosis hepatis, often a 0.3 to 3.0 cm large lesion represents  blood-filled, cystically dilated 
sinusoids without cellular lining (Zak, 1950). They are randomly distributed throughout the 
liver. Thus, the decision to transplant will largely depend on their size and number as well 
as their potential negative effect on liver function, particularly since etiologically different 
infectious diseases have to be considered (Bartonella Henselae, tuberculosis, HIV, S. aureus). 
Two subtypes are important (Yanoff&Rawson, 1964): the parenchymatous subtype is 
associated with hemorrhagic necroses, while the phlebic subtype is characterized by dilated 
sinusoids. However, peliosis has to be differentiated from other lesions such as biliary 
hamartomas, liver cysts and most frequently from all lesions resulting from acute 
congestion due to acute right heart insufficiency. Here, the lesion’s pericental accentuation, 
and the lack of cystic structures are important in the diagnosis. 
Heterotopias in the liver are rarely encountered, such as ectopic pancreatic tissue within 
heterotopic duct cysts (Schaefer et al., 1989). 
Again, in most cases, a frozen section of the lesion after total excision will bring a 
satisfactory answer. However, livers were rejected on the ground of such a lesion described 
by the transplant surgeon, which were not biopsied as part of the decision process, although 
the subsequent histological evaluation of this liver (analyzing all 8 segments, and the 
vessels/ bile ducts of the hilar region histopathologically) clearly indicated that this had been 
a benign process, which should not have led to transplant rejection. There may have been 
other reasons unknown to us leading to the rejection of the liver. Considering the organ 
shortage and cost and effect of a frozen section, potentially supporting a decision of 
rejection, we would advise to perform a frozen section of such lesions in most cases, even if 
it would be only for providing an irrevocable proof of non-transplantability to the relatives 
of the decreased. Any rejection has to be seen as disregarding the last wish of the deceased 
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or the relatives, which in our opinion should be well justified. Furthermore, for future 
efforts to improve the transplantation rate it seems prudent that the transfer of information 
potentially leading to a decision of rejection are becoming more transparent and accessible 
in an epidemiologic databank for future analysis. 
Once the histopathological evaluation is performed, the result should be documented on the 
appropriate transplant form, including the number of frozen sections taken, the quality of 
the tissue and whether it is sufficient for analysis, the actual histologic evaluation separately 
for each frozen section/ each segment, and the final assessment, whether or not the liver is 
good/ acceptable/ poor as transplant organ from a histopathological perspective. This last 
addendum is important in cases in which the evaluation between transplant surgeon and 
pathologist differs to the point that the organ is rejected. Pathological evaluations may result 
in transplantable appearing organs; however, several other reasons may prevent the 
surgeon from following this advice. Among them are problems with the donor organ 
concerning the reconstruction of the hilar vessels (anomalies) and the bile ducts (major bile 
duct too small, anomalies) as well as problems concerning the transplant acceptor. Thus, in 
the databank regarding the evaluation sheet from a rejected organ, the reasons and the 
person responsible for the rejection should be clearly stated.     
7. Histopathological evaluation after organ procurement 
Once the histologic evaluation of the frozen section is concluded, the remaining tissue is 
postfixed overnight as is the remaining part of the wedge biopsy in buffered, 4% formalin, pH 
7.4. The pH of the formalin used should be pre-monitored: commercially available formalin 
solution may differ in its pH from highly acidic to basic values, all of which being sold as 
“buffered”. The day after paraffin embedding, 3 to 4-µm-thick sections should be cut and 
routinely stained. A typical standard series of stains (besides H&E) should include: a Gomori’s 
stain (as fibrotic marker), a PAS stain (for best histologic resolution of hepatocytes and sinuses) 
, and an iron stain such as Berlin blue (for iron deposition). An elastic van Gieson stain may be 
added, however, it does not provide any advantage; in contrast, it proves less sensitive in 
detecting fibrosis. If microvesicular staetosis is a major feature - at least if it was one major 
reason for rejection – a Sudan stain for fat should be included in the list.  
One should carefully select the tissue sections to be stained. It seems unnecessary to stain 
every single one with all stains to be considered. Instead, a representative postfixed section 
from the primarily frozen tissue as well as one of the primarily formalin-fixed tissue should 
be selected for this purpose. The remaining tissue (mostly rest tissue from the wedge) 
should be evaluated primarily by H&E. If there is any question, one still has the opportunity 
to analyse these tissue portions by additional stains as well.  
A discrepancy between the frozen sections analysis and the histopathologic analysis after 
organ procurement should be reported immediately to the transplant centre. In our 
experience, this is a very rare occasion: in revaluating the biopsy sites of previous frozen 
section excisions, we found only one out of 50 biopsies, whose basic diagnosis and 
evaluation mismatched distinctly. In this case, however, the diagnosis of a major degree of 
steatosis was made on biopsy, which could neither be found by re-evaluating the former 
(single!) biopsy site in the third liver segment nor by analysing all other segments of the 
rejected liver. Unfortunately, the biopsy could not be retrieved to be re-analysed as well, 
which should be the recommendation in such cases so as to learn more about the reason. 
Another aspect of evaluation is the analysis of hepatocellular iron deposition. By frozen 
section and without further stains, the differential of hemosiderin (containing iron), and 
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hematoidin (containing no iron) is impossible. Therefore, we recommend a Berliner blue 
reaction, which will provide a blue precipitate in cases of hemosiderin, but not with 
hematoidin deposition. 
8. Conclusion 
Continuously collecting clinical, surgical, and histopathologic data in a central registry of all 
transplanted livers may provide valuable information as to whether the evaluation at time of 
transplantation was correct. If a posttransplant biopsy is taken after liver transplantation, the 
results of its histopathologic evaluation should likewise be collected in the same registry. This 
measure will improve our knowledge of the importance of morphological alterations and their 
significance at the time of transplantation. If the liver is rejected as transplant organ, these 
pieces of information may provide the basis for consoling relatives of the deceased about the 
reasons for not transplanting the organ and thus acting against his or her last will.  
Furthermore, routine control biopsies, in intervals such as 12 months, three years and 
beyond, may provide valuable information whether or not organs regarded as marginally 
suitable due to histologic alterations, especially microvesicular versus macrovesicular fat 
accumulation, are able to recover. In case of death of the transplant recipient, liver 
evaluation by biopsy or autopsy should become a routine investigation in order to 
retrospectively control the transplant decision. 
9. Addendum 
 
Fig. 9. Flow sheet: “Frozen Section Differential Diagnosis of Hepatic Focal Lesions”  
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